TONGRENTANGCM Secures Hong Kong Registration for “Dingzhi Wan”, Broadening Chinese-Medicine Portfolio

Bulletin Express

Oct 08

Beijing Tong Ren Tang Chinese Medicine Company Limited (TONGRENTANGCM) has obtained a Certificate of Registration of Proprietary Chinese Medicine from the Chinese Medicine Council of Hong Kong, authorising the sale of “Dingzhi Wan【Tong Ren Tang】” (registration number: HKC-18863) in the Hong Kong market until 29 September 2031.

The traditional Chinese medicine is indicated for supplementing qi, nourishing the heart, and calming the mind, targeting conditions such as heart-qi instability and related symptoms of restlessness, forgetfulness, and vertigo.

TONGRENTANGCM has invested approximately HK$0.80 million to date in the product’s research and development. Commercial launch has not yet commenced.

Management expects the new registration to enrich the company’s product line and support market expansion in Hong Kong. No material impact on current operations or financial performance is anticipated. The company notes that future sales may be influenced by regulatory changes, currency movements, and competitive dynamics in the Hong Kong market.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1184238234"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1184238234\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1184238234?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-08 17:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1184238234","market":"hk","top_or_hot":-1,"title":"TONGRENTANGCM Secures Hong Kong Registration for “Dingzhi Wan”, Broadening Chinese-Medicine Portfolio","media":"Bulletin Express","content":"<p>Beijing Tong Ren Tang Chinese Medicine Company Limited (TONGRENTANGCM) has obtained a Certificate of Registration of Proprietary Chinese Medicine from the Chinese Medicine Council of Hong Kong, authorising the sale of “Dingzhi Wan【Tong Ren Tang】” (registration number: HKC-18863) in the Hong Kong market until 29 September 2031.</p>\n<p>The traditional Chinese medicine is indicated for supplementing qi, nourishing the heart, and calming the mind, targeting conditions such as heart-qi instability and related symptoms of restlessness, forgetfulness, and vertigo.</p>\n<p>TONGRENTANGCM has invested approximately HK$0.80 million to date in the product’s research and development. Commercial launch has not yet commenced.</p>\n<p>Management expects the new registration to enrich the company’s product line and support market expansion in Hong Kong. No material impact on current operations or financial performance is anticipated. The company notes that future sales may be influenced by regulatory changes, currency movements, and competitive dynamics in the Hong Kong market.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TONGRENTANGCM Secures Hong Kong Registration for “Dingzhi Wan”, Broadening Chinese-Medicine Portfolio</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTONGRENTANGCM Secures Hong Kong Registration for “Dingzhi Wan”, Broadening Chinese-Medicine Portfolio\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-10-08 17:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Beijing Tong Ren Tang Chinese Medicine Company Limited (TONGRENTANGCM) has obtained a Certificate of Registration of Proprietary Chinese Medicine from the Chinese Medicine Council of Hong Kong, authorising the sale of “Dingzhi Wan【Tong Ren Tang】” (registration number: HKC-18863) in the Hong Kong market until 29 September 2031.</p>\n<p>The traditional Chinese medicine is indicated for supplementing qi, nourishing the heart, and calming the mind, targeting conditions such as heart-qi instability and related symptoms of restlessness, forgetfulness, and vertigo.</p>\n<p>TONGRENTANGCM has invested approximately HK$0.80 million to date in the product’s research and development. Commercial launch has not yet commenced.</p>\n<p>Management expects the new registration to enrich the company’s product line and support market expansion in Hong Kong. No material impact on current operations or financial performance is anticipated. The company notes that future sales may be influenced by regulatory changes, currency movements, and competitive dynamics in the Hong Kong market.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03613","symbol_name":"同仁堂国药","start_time":0,"source_url":"","article_id":"1184238234","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1184238234","pubTimestamp":1791452531,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Beijing Tong Ren Tang Chinese Medicine Company Limited (TONGRENTANGCM) has obtained a Certificate of Registration of Proprietary Chinese Medicine from the Chinese Medicine Council of Hong Kong,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03613":"同仁堂国药"},"translate_title":"同仁堂医药“定脂丸”获香港注册，扩大中药产品组合","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03613":1},"content_text":"Beijing Tong Ren Tang Chinese Medicine Company Limited (TONGRENTANGCM) has obtained a Certificate of Registration of Proprietary Chinese Medicine from the Chinese Medicine Council of Hong Kong, authorising the sale of “Dingzhi Wan【Tong Ren Tang】” (registration number: HKC-18863) in the Hong Kong market until 29 September 2031.\nThe traditional Chinese medicine is indicated for supplementing qi, nourishing the heart, and calming the mind, targeting conditions such as heart-qi instability and related symptoms of restlessness, forgetfulness, and vertigo.\nTONGRENTANGCM has invested approximately HK$0.80 million to date in the product’s research and development. Commercial launch has not yet commenced.\nManagement expects the new registration to enrich the company’s product line and support market expansion in Hong Kong. No material impact on current operations or financial performance is anticipated. The company notes that future sales may be influenced by regulatory changes, currency movements, and competitive dynamics in the Hong Kong market.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}